Orphazyme A/S ADR (ORPHY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2021 | 12-2020 | 12-2019 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | 16,269 | 111,366 | N/A |
| Receivables | 5,807 | 843 | N/A |
| TOTAL | $25,288 | $120,057 | $N/A |
| Non-Current Assets | |||
| PPE Net | 475 | 718 | N/A |
| Intangibles | 342 | 1,908 | 0 |
| Other Non-Current Assets | 1,455 | 3,323 | 0 |
| TOTAL | $2,273 | $5,949 | $N/A |
| Total Assets | $27,561 | $126,006 | $N/A |
| Liabilities | |||
| Current Liabilities | |||
| Short Term Debt | 4,929 | 5,109 | N/A |
| Accounts payable and accrued liabilities | 9,152 | 11,051 | 0 |
| Other current liabilities | 5,954 | 8,170 | N/A |
| TOTAL | $20,539 | $25,527 | $N/A |
| Non-Current Liabilities | |||
| Long Term Debt | 395 | 3,651 | N/A |
| Other Non-Current Liabilities | 4,517 | 250 | 0 |
| TOTAL | $5,536 | $5,414 | $N/A |
| Total Liabilities | $26,075 | $30,942 | $N/A |
| Shareholders' Equity | |||
| Common Shares | 5,561 | 5,316 | N/A |
| Retained earnings | -335,860 | -230,248 | N/A |
| Other shareholders' equity | 461 | 995 | 0 |
| TOTAL | $1,486 | $95,064 | $N/A |
| Total Liabilities And Equity | $27,561 | $126,006 | $0 |